Upstate Active Clinical Trials
Study Title:A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab with Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with unresected Stage I/II, lymph-node negative Non-small Cell Lung Cancer (PACIFIC-4/RTOG-3515)
Upstate Institutional Review Board (IRB) Number:1387295
Patient Age Group:Adults
Principal Investigator:Michael D Mix, MD
What is involved if I participate?
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
Where will the study take place?Radiation Oncology Oswego, Oneida, and The Hill - SBRT and informed consent
SUNY Upstate Cancer Center - all procedures
Medical Oncology Oswego and Oneida - consent only
Who can I contact for more information?
Name: Erin Bingham